Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells

• Jun Shimizu,
• Tadahiro Sasaki,
• Ritsuko Koketsu,
• Ryo Morita,
• Yuka Yoshimura,
• Ami Murakami,
• Yua Saito,
• Toshie Kusunoki,
• Yoshihiro Samune,
• Emi E. Nakayama,
• Kazuo Miyazaki,
• Tatsuo Shioda

Affiliations

Jun Shimizu

MiCAN Technologies Inc

Tadahiro Sasaki

Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University

Ritsuko Koketsu

Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University

Ryo Morita

Osaka City Juso Hospital

Yuka Yoshimura

MiCAN Technologies Inc

Ami Murakami

MiCAN Technologies Inc

Yua Saito

MiCAN Technologies Inc

Toshie Kusunoki

MiCAN Technologies Inc

Yoshihiro Samune

Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University

Emi E. Nakayama

Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University

Kazuo Miyazaki

MiCAN Technologies Inc

Tatsuo Shioda

Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University